Back

Inhibition of sodium conductance by cannabigerol contributes to a reduction of neuronal dorsal root ganglion excitability

Ghovanloo, M.-R.; Estacion, M.; zhao, P.; Dib-Hajj, S.; Waxman, S. G.

2021-09-16 pharmacology and toxicology
10.1101/2021.09.14.460359 bioRxiv
Show abstract

Cannabigerol (CBG), a non-psychotropic phytocannabinoid, is a precursor for cannabis derivatives, {Delta}9-tetrahydrocannabinol and cannabidiol (CBD). Like CBD, CBG has been suggested as an analgesic. A previous study reported CBG (10 M) blocks voltage-gated sodium (Nav) currents in CNS neurons. However, the manner in which CBG inhibits Nav channels, and whether this effect contributes to CBGs potential analgesic behavior remain unknown. Genetic and functional studies have validated Nav1.7 as an opportune target for analgesic drug development. The efforts to develop therapeutic selective Nav1.7 blockers have been unsuccessful thus far, possibly due to issues in occupancy; drugs have been administered at concentrations many folds above IC50, resulting in loss of isoform-selectivity, and increasing off-target effects. We reasoned that an alternative approach could use compounds possessing 2 important properties: ultra-hydrophobicity and functional selectivity. Hydrophobicity could enhance absorption into neuronal cells especially with local administration. Functional selectivity could reduce likelihood of side-effects. As CBG is ultra-hydrophobic (cLogD=7.04), we sought to determine whether it also possesses functional selectivity against Nav channels that are expressed in dorsal root ganglion (DRG). We found that CBG is a ~10-fold state-dependent Nav inhibitor (KI-KR: ~2-20 M) with an average Hill-slope of ~2. We determined that at lower concentrations, CBG predominantly blocks sodium Gmax and slows recovery from inactivation; however, as concentration is increased, CBG also hyperpolarizes Nav inactivation curves. Our modeling and multielectrode array recordings suggest that CBG attenuates DRG excitability, which is likely linked with Nav inhibition. As most Nav1.7 channels are inactivated at DRG resting membrane potential, they are more likely to be inhibited by lower CBG concentrations, suggesting functional selectivity against Nav1.7 compared to other Navs (via Gmax block).

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
British Journal of Pharmacology
40 papers in training set
Top 0.1%
31.2%
2
eLife
5828 papers in training set
Top 7%
11.9%
3
Frontiers in Pharmacology
111 papers in training set
Top 0.2%
9.7%
50% of probability mass above
4
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.1%
4.9%
5
ACS Chemical Neuroscience
67 papers in training set
Top 0.2%
4.3%
6
Biophysical Journal
631 papers in training set
Top 2%
3.4%
7
European Journal of Pharmacology
15 papers in training set
Top 0.1%
3.3%
8
PLOS ONE
5266 papers in training set
Top 37%
3.3%
9
Scientific Reports
3612 papers in training set
Top 33%
3.2%
10
The Journal of Pharmacology and Experimental Therapeutics
18 papers in training set
Top 0.2%
1.7%
11
Journal of Biological Chemistry
690 papers in training set
Top 6%
1.5%
12
Molecular Pharmaceutics
16 papers in training set
Top 0.2%
1.3%
13
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 34%
1.1%
14
Molecular Pharmacology
17 papers in training set
Top 0.1%
1.1%
15
Biochemical Pharmacology
20 papers in training set
Top 0.3%
1.0%
16
Neuropharmacology
68 papers in training set
Top 0.8%
0.8%
17
Clinical and Translational Medicine
31 papers in training set
Top 1%
0.6%
18
Toxicological Sciences
41 papers in training set
Top 0.6%
0.6%
19
Science Advances
1243 papers in training set
Top 33%
0.6%
20
Communications Biology
993 papers in training set
Top 34%
0.6%
21
Pharmacology Research & Perspectives
11 papers in training set
Top 0.4%
0.6%
22
iScience
1154 papers in training set
Top 39%
0.6%
23
Toxins
14 papers in training set
Top 0.2%
0.6%